Silo Pharma Files 2024 Proxy Statement

TL;DR

Silo Pharma (SILO) filed its proxy statement for the Nov 12 meeting - shareholders vote soon.

AI Summary

Silo Pharma, Inc. filed a DEF 14A proxy statement on September 18, 2024, for its annual meeting on November 12, 2024. The company, previously known as Uppercut Brands, Inc., is in the pharmaceutical preparations industry and is incorporated in Nevada. The filing details information relevant to shareholders for the upcoming meeting.

Why It Matters

This filing provides shareholders with crucial information to vote on company matters at the upcoming annual meeting, impacting corporate governance and future strategic decisions.

Risk Assessment

Risk Level: low — This filing is a routine proxy statement and does not contain new financial or operational risks.

Key Numbers

• 20241112 — Annual Meeting Date (Shareholders will vote on company matters on this date.)
• 20240918 — Filing Date (Date the proxy statement was submitted to the SEC.)

Key Players & Entities

• Silo Pharma, Inc. (company) — Registrant
• 20240918 (date) — Filing Date
• 20241112 (date) — Meeting Date
• Uppercut Brands, Inc. (company) — Former Company Name

FAQ

Key Financial Figures

• $8,000 — nnual Meeting at an approximate cost of $8,000, plus reimbursement of expenses. If you

Filing Documents

• ea0214566-01.htm (DEF 14A) — 833KB
• tcampaign_logo.jpg (GRAPHIC) — 51KB
• tproxy_001.jpg (GRAPHIC) — 1022KB
• tproxy_002.jpg (GRAPHIC) — 1252KB
• tproxy_003.jpg (GRAPHIC) — 739KB
• 0001213900-24-079883.txt ( ) — 5055KB

From the Filing

DEF 14A 1 ea0214566-01.htm PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________ Schedule 14A _________________________________ Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.    ) Filed by the Registrant   Filed by a Party other than the Registrant   Check the appropriate box:   Preliminary Proxy Statement   Confidential, for Use of the Commission Only (as permitted by Rule 14a -6 (e)(2))   Definitive Proxy Statement   Definitive Additional Materials   Soliciting Material under § 240.14a -12 SILO PHARMA, INC. (Name of Registrant as Specified In Its Charter) ______________________________________________________________ (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) Payment of Filing Fee (Check all boxes that apply):   No fee required   Fee paid previously with preliminary materials.   Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a- 6(i)(1) and 0 -11   SILO PHARMA, INC. 677 N Washington Boulevard Sarasota, Florida 34236 NOTICE OF ANNUAL MEETING OF STOCKHOLDERS To Be Held on November 12, 2024 Dear Stockholders: The 2024 Annual Meeting of Stockholders (the “ 2024 Annual Meeting ” or, “ Annual Meeting ”) of Silo Pharma, Inc., a Nevada corporation (the “Company,” “we,” “us,” or “our”), will be held on November 12, 2024, at 11:00 a.m. Eastern Time at our office located at 677 N Washington Boulevard, Sarasota, Florida 34236. At the 2024 Annual Meeting, the holders of our outstanding common stock will act on the following matters: 1.        To elect four (4) members to our Board of Directors to serve for a one -year term to expire at the 2025 annual meeting of shareholders; 2.        To ratify the appointment of Salberg & Company, P.A. (“ Salberg ”) as our independent registered public accounting firm for the fiscal year ending December 31, 2024; 3.        To approve, by non -binding advisory vote, the resolution approving named executive officer compensation (the “ Say on Pay Proposal ”); 4.        To approve, by non -binding advisory vote, the frequency of future non -binding advisory votes on resolutions approving future named executive officer compensation (the “ Say When on Pay Proposal ”); 5.        To authorize the adjournment of the Annual Meeting if necessary or appropriate, including to solicit additional proxies in the event that there are not sufficient votes at the time of the Annual Meeting or adjournment or postponement thereof to approve any of the foregoing proposals (the “ Adjournment Proposal ”); and 6.        To transact such other business as may properly come before the meeting or any adjournment or postponement thereof. Our Board unanimously recommends that you vote “ FOR ” the election of our Board’s director nominees (Proposal 1); “ FOR ” the ratification of the appointment of Salberg as our independent registered public accounting firm for the fiscal year ending December 31, 2024 (Proposal 2); “ FOR ” the approval of the Say on Pay Proposal (Proposal 3); for “ THREE YEARS ” on the preferred frequency the approval of the Say When on Pay Proposal (Proposal 4); and “ FOR ” the approval of the Adjournment Proposal (Proposal 5). Instead of mailing a printed copy of our proxy materials to all of our stockholders, we provide access to these materials via the Internet. This reduces the amount of paper necessary to produce these materials as well as the costs associated with mailing these materials to all stockholders. Accordingly, on or about September 18, 2024, we will begin mailing a Notice of Internet Availability of Proxy Materials (the “ Notice ”) to all stockholders of record on our books at the close of business on September 13, 2024, the record date for the 2024 Annual Meeting, and will post our proxy materials on the website referenced in the Notice. As more fully described in the Notice, stockholders may choose to access our proxy materials on the website referred to in the Notice or may request to receive a printed set of our proxy materials. In addition, the Notice and website provide information regarding how you may request to receive proxy materials in printed

View Full Filing

View this DEF 14A filing on SEC EDGAR